Ra Capital Management, L.P.

Ra Capital Management, L.P. reported 92 holdings worth US$9.97B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Ra Capital Management, L.P. reported 92 holdings worth US$9.97B as of Sep 30, 2026. Largest: Parabilis Medicines, Inc., Vaxcyte, Inc. and Rhythm Pharmaceuticals, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
92
Value as reported
US$9.97B

The filing in full

CompanySharesValue as reported% of portfolio
Parabilis Medicines, Inc.29.2MUS$942M9.5%
Vaxcyte, Inc.11.5MUS$653M6.5%
Rhythm Pharmaceuticals, Inc.6.67MUS$635M6.4%
Edgewise Therapeutics, Inc.8.39MUS$341M3.4%
Tyra Biosciences, Inc.12.2MUS$267M2.7%
Freenome, Inc.15.4MUS$242M2.4%
Hemab Therapeutics Holdings, Inc.7.81MUS$241M2.4%
Septerna, Inc.5.5MUS$215M2.2%
SpyGlass Pharma, Inc.8.02MUS$209M2.1%
Janux Therapeutics, Inc.11.2MUS$193M1.9%
Mineralys Therapeutics, Inc.7.69MUS$193M1.9%
Disc Medicine, Inc.2.45MUS$160M1.6%
Taysha Gene Therapies, Inc.30.4MUS$148M1.5%
Bicara Therapeutics Inc.7.26MUS$135M1.4%
Artiva Biotherapeutics, Inc.18.5MUS$132M1.3%
Xencor, Inc.5.27MUS$132M1.3%
Oruka Therapeutics, Inc.1.55MUS$129M1.3%
Amylyx Pharmaceuticals, Inc.4.28MUS$125M1.2%
Climb Bio, Inc.10.1MUS$116M1.2%
Abivax SA1.03MUS$102M1.0%
Latigo Biotherapeutics, Inc.5.3MUS$88.6M0.89%
Solid Biosciences Inc.12MUS$87M0.87%
Vor Biopharma Inc.4.5MUS$85.9M0.86%
LB Pharmaceuticals Inc2.21MUS$84.8M0.85%
Obsidian Therapeutics, Inc.5.96MUS$81.8M0.82%
Zai Lab Ltd.2.82MUS$74.2M0.74%
4D Molecular Therapeutics, Inc.5.05MUS$72.3M0.72%
Aclaris Therapeutics, Inc.12.7MUS$66.9M0.67%
Sana Biotechnology, Inc.18.8MUS$54.7M0.55%
Monopar Therapeutics Inc.667KUS$53.2M0.53%
Geron Corporation42.8MUS$52.6M0.53%
PepGen Inc.20.1MUS$48.6M0.49%
ARS Pharmaceuticals, Inc.10.9MUS$46.8M0.47%
Acumen Pharmaceuticals, Inc.21MUS$46.6M0.47%
DBV Technologies SA3.66MUS$43M0.43%
Agenus Inc.4.12MUS$40.9M0.41%
Rezolute, Inc.9.45MUS$39.1M0.39%
Sionna Therapeutics, Inc.6.46MUS$34M0.34%
Scribe Therapeutics Inc.1.8MUS$33.2M0.33%
Century Therapeutics, Inc.17.8MUS$30.4M0.30%
Evommune, Inc.3.49MUS$28.9M0.29%
Capricor Therapeutics, Inc.3.01MUS$28.5M0.29%
Nkarta, Inc.10.8MUS$28.3M0.28%
C4 Therapeutics, Inc.8.19MUS$27.3M0.27%
Jade Biosciences, Inc.1.84MUS$25.8M0.26%
Prelude Therapeutics Incorporated6.48MUS$25.3M0.25%
Acrivon Therapeutics, Inc.12.2MUS$25.1M0.25%
Assembly Biosciences, Inc.1.02MUS$24M0.24%
Editas Medicine, Inc.8.89MUS$22.8M0.23%
Q32 Bio Inc.2.33MUS$19.3M0.19%
Anteris Technologies Global Corp.2.47MUS$19.2M0.19%
Electra Therapeutics, Inc.1.69MUS$19M0.19%
Altimmune, Inc.6.5MUS$18.6M0.19%
Benitec Biopharma Inc.1.85MUS$18.5M0.19%
ALX Oncology Holdings Inc.13MUS$18.1M0.18%
Sagimet Biosciences Inc. - Series A1.8MUS$17.8M0.18%
Lexeo Therapeutics, Inc.5MUS$16.9M0.17%
LENZ Therapeutics, Inc.4.18MUS$16M0.16%
Aura Biosciences, Inc.2.5MUS$15.7M0.16%
Avalo Therapeutics, Inc.1MUS$15.3M0.15%
Inhibikase Therapeutics, Inc.6.97MUS$14.3M0.14%
Seaport Therapeutics, Inc.700KUS$14.1M0.14%
SAB Biotherapeutics, Inc.4.4MUS$14M0.14%
Ovid Therapeutics Inc.5.6MUS$13.9M0.14%
Mirum Pharmaceuticals, Inc.159KUS$13.6M0.14%
Helix Acquisition Corp. III1.25MUS$13.3M0.13%
Bright Minds Biosciences Inc.265KUS$13.2M0.13%
Corbus Pharmaceuticals Holdings, Inc.1.91MUS$13.1M0.13%
Braveheart Bio, Inc.565KUS$11.4M0.11%
OnKure Therapeutics, Inc.4MUS$10.9M0.11%
Palisade Bio, Inc.7.12MUS$9.62M0.10%
Inovio Pharmaceuticals, Inc.7.22MUS$8.81M0.09%
MacroGenics, Inc.1.86MUS$7.2M0.07%
Rani Therapeutics Holdings, Inc.8.5MUS$6.72M0.07%
Adicet Bio, Inc.933KUS$6.66M0.07%
TCGX Acquisition Corp.500KUS$6.25M0.06%
Sensei Biotherapeutics, Inc.205KUS$6.1M0.06%
JATT II Acquisition Corp500KUS$5.62M0.06%
JATT III Acquisition Corp450KUS$4.96M0.05%
Amanat Acquisition Corp375KUS$4M0.04%
Equillium, Inc.2.32MUS$3.77M0.04%
Sutro Biopharma, Inc.211KUS$3.4M0.03%
Stoke Therapeutics, Inc.73,607US$1.91M0.02%
Palatin Technologies, Inc.62,124US$551K<0.01%
Werewolf Therapeutics, Inc.0US$00.00%
Karyopharm Therapeutics Inc.0US$00.00%
Intellia Therapeutics, Inc.0US$00.00%
Nuvalent, Inc.0US$00.00%
Perceptive Capital Solutions Corp0US$00.00%
Waystar Holding Corp.0US$00.00%
Aktis Oncology, Inc.0US$00.00%
BioCryst Pharmaceuticals, Inc.0US$00.00%
BioAge Labs, Inc.0US$00.00%
Corvus Pharmaceuticals, Inc.0US$00.00%
Definium Therapeutics, Inc.0US$00.00%
Damora Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related